Mini-transplants turning micro: How low can we go?

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 6, 2002, Pages 859-862

  Klingemann, Hans G ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUDARABINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER REGRESSION; CELL ACTIVATION; CELL COUNT; CHIMERA; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE RELEASE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MYELOMA; NOMENCLATURE; NONHODGKIN LYMPHOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TOXICITY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PRACTICE GUIDELINES; TRANSPLANTATION IMMUNOLOGY;

EID: 0036977812     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602321080510     Document Type: Review

References (12)

1. Porter DL. (2001). The graft-versus-tumor potential of allogeneic cell therapy: An update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation. J Hematother Stem Cell Res 10:465-480.
2. McSweeney PA, D Niederwieser, JA Shizuru, BM Sandmaier, AJ Molina, DG Maloney, TR Chauncey, TA Goooley, U Hegenbart, RA Nash, NJ Radich, JL Wagner, S Minor, FR Appelbaum, WI Bensinger, E Bryant, MED Flowers, GE Georges, FC Grumet, HP Kiem, B Torok-Storb, C Yu, KG Blume and RF Storb. (2001). Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 11:3390-3400.
3. Khouri IF, M Keating, M Korbling, D Przepiorka, P Anderlini, S O'Brien, S Giralt, C Ippoliti, B von Wolff, J Gajewski, M Donato, D Claxton, N Ueno, B Andersson, A Gee and R Champlin. (1998). Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 16:2817-2824.
4. Childs R, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, EJ Read, C Carter, E Bahceci, NS Young and AJ Barrett. (1999). Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune response. Blood 9:3234-3250.
5. Orsini E, EP Alyea, A Chillemi, R Schlossman, S McLaughlin, C Canning, RJ Soiffer, KC Anderson and J Ritz. (2000). Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma. Biol Blood Marrow Transplant 6:375-386.
6. Ballen KK, PS Becker, RVB Emmons, TJ Fitzgerald, CC Hsieh, Q Liu, C Heyes, Y Clark, W Levy, JF Lambert, F Chiafari, I Szymanski and S Rososhansky. (2002). Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood 100:442-450.
7. Childs R, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, EJ Read, J Tisdale, C Dunbar, WM Linehan, NS Young and AJ Barrett. (2000). Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. New Engl J Med 343:750-758.
8. Porter DL, JM Conners, VM Van Deerlin, et al. (1999). Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancy. J Clin Oncol 17:1234-1237.
9. O'Donnell PV, L Luznik, RJ Jones, GB Vogelsang, MS Leffell, M Phelps, P Rhubart, K Cowan, S Piantadosi and EJ Fuchs. (2002). Non-myeloablative bone marrow transplantation from partially HLA-mismatched related donors using post transplantation cyclophosphamide. Biol Blood Marrow Transplant 8:377-386.
10. Dey BR, SL McAffee, R Sackstein et al. (2001). Achievement of sustained remissions despite loss of donor chimerism (DC) in patients with chemotherapy-refractory non-Hodgkin's lymphoma (NHL) treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Blood 98:1735a.
11. Lee T-H, T Paglieroni, H Ohto, PV Holland and MP Busch. (1999). Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 93:3127-3139.
12. Kruskall MS, T-H Lee, SF Assmann, M Laycock, LA Kalih, MM Lederman and MP Busch. (2001). Survival of transfused donor white blood cells in HIV-infected recipients. Blood 98:272-279.